Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01652378 · ClinicalTrials.gov registry record
Pharmacologic MRI in Cocaine Addiction
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 12
- Enrollment target
NCT01652378 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT01652378 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
In the proposed study, the investigators will assess the brain response to medication probes the investigators have previously studied with SPECT. The brain response to ondansetron and lidocaine infusions will be measured Arterial Spin Labeling and functional connectivity MRI (fcMRI).
Interventions
- DRUG ondansetron, lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01652378
The ClinicalTrials.gov registry entry for NCT01652378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ondansetron, lidocaine is the first listed.
NCT01652378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01652378 about?
NCT01652378 is a clinical study titled "Pharmacologic MRI in Cocaine Addiction". In the proposed study, the investigators will assess the brain response to medication probes the investigators have previously studied with SPECT. The brain response to ondansetron and lidocaine infusions will be measured Arterial Spin Labeling and functional connectivity MRI (fcMRI).
What is the current status of trial NCT01652378?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2012-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01652378?
The interventions under investigation include: ondansetron, lidocaine (DRUG).
Who is sponsoring clinical trial NCT01652378?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.